213 related articles for article (PubMed ID: 12168660)
1. RNA splicing mediated by YB-1 is inhibited by TLS/CHOP in human myxoid liposarcoma cells.
Rapp TB; Yang L; Conrad EU; Mandahl N; Chansky HA
J Orthop Res; 2002 Jul; 20(4):723-9. PubMed ID: 12168660
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein.
Chansky HA; Hu M; Hickstein DD; Yang L
Cancer Res; 2001 May; 61(9):3586-90. PubMed ID: 11325824
[TBL] [Abstract][Full Text] [Related]
3. Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma.
Kuroda M; Ishida T; Horiuchi H; Kida N; Uozaki H; Takeuchi H; Tsuji K; Imamura T; Mori S; Machinami R
Am J Pathol; 1995 Nov; 147(5):1221-7. PubMed ID: 7485386
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation.
Kanoe H; Nakayama T; Hosaka T; Murakami H; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Ron D; Sasaki MS; Toguchida J
Oncogene; 1999 Jan; 18(3):721-9. PubMed ID: 9989822
[TBL] [Abstract][Full Text] [Related]
5. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma.
Crozat A; Aman P; Mandahl N; Ron D
Nature; 1993 Jun; 363(6430):640-4. PubMed ID: 8510758
[TBL] [Abstract][Full Text] [Related]
6. FUS/TLS-CHOP chimeric transcripts in liposarcoma tissues.
Yang X; Nagasaki K; Egawa S; Maruyama K; Futami H; Tsukada T; Yokoyama R; Beppu Y; Fukuma H; Shimoda T
Jpn J Clin Oncol; 1995 Dec; 25(6):234-9. PubMed ID: 8523819
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein.
Kuroda M; Ishida T; Takanashi M; Satoh M; Machinami R; Watanabe T
Am J Pathol; 1997 Sep; 151(3):735-44. PubMed ID: 9284822
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.
Antonescu CR; Tschernyavsky SJ; Decuseara R; Leung DH; Woodruff JM; Brennan MF; Bridge JA; Neff JR; Goldblum JR; Ladanyi M
Clin Cancer Res; 2001 Dec; 7(12):3977-87. PubMed ID: 11751490
[TBL] [Abstract][Full Text] [Related]
9. Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements.
Antonescu CR; Elahi A; Healey JH; Brennan MF; Lui MY; Lewis J; Jhanwar SC; Woodruff JM; Ladanyi M
Clin Cancer Res; 2000 Jul; 6(7):2788-93. PubMed ID: 10914725
[TBL] [Abstract][Full Text] [Related]
10. A novel FUS/CHOP chimera in myxoid liposarcoma.
Panagopoulos I; Mertens F; Isaksson M; Mandahl N
Biochem Biophys Res Commun; 2000 Dec; 279(3):838-45. PubMed ID: 11162437
[TBL] [Abstract][Full Text] [Related]
11. Liposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma.
Pérez-Losada J; Sánchez-Martín M; Rodríguez-García MA; Pérez-Mancera PA; Pintado B; Flores T; Battaner E; Sánchez-Garćia I
Oncogene; 2000 Dec; 19(52):6015-22. PubMed ID: 11146553
[TBL] [Abstract][Full Text] [Related]
12. Fusion of the EWS and CHOP genes in myxoid liposarcoma.
Panagopoulos I; Höglund M; Mertens F; Mandahl N; Mitelman F; Aman P
Oncogene; 1996 Feb; 12(3):489-94. PubMed ID: 8637704
[TBL] [Abstract][Full Text] [Related]
13. Expression of the FUS domain restores liposarcoma development in CHOP transgenic mice.
Pérez-Mancera PA; Pérez-Losada J; Sánchez-Martín M; Rodríguez-García MA; Flores T; Battaner E; Gutiérrez-Adán A; Pintado B; Sánchez-García I
Oncogene; 2002 Mar; 21(11):1679-84. PubMed ID: 11896599
[TBL] [Abstract][Full Text] [Related]
14. Characteristic sequence motifs at the breakpoints of the hybrid genes FUS/CHOP, EWS/CHOP and FUS/ERG in myxoid liposarcoma and acute myeloid leukemia.
Panagopoulos I; Lassen C; Isaksson M; Mitelman F; Mandahl N; Aman P
Oncogene; 1997 Sep; 15(11):1357-62. PubMed ID: 9315104
[TBL] [Abstract][Full Text] [Related]
15. Translin binds to the sequences adjacent to the breakpoints of the TLS and CHOP genes in liposarcomas with translocation t(12;6).
Hosaka T; Kanoe H; Nakayama T; Murakami H; Yamamoto H; Nakamata T; Tsuboyama T; Oka M; Kasai M; Sasaki MS; Nakamura T; Toguchida J
Oncogene; 2000 Nov; 19(50):5821-5. PubMed ID: 11126370
[TBL] [Abstract][Full Text] [Related]
16. Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma.
Riggi N; Cironi L; Provero P; Suvà ML; Stehle JC; Baumer K; Guillou L; Stamenkovic I
Cancer Res; 2006 Jul; 66(14):7016-23. PubMed ID: 16849546
[TBL] [Abstract][Full Text] [Related]
17. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP.
Zinszner H; Albalat R; Ron D
Genes Dev; 1994 Nov; 8(21):2513-26. PubMed ID: 7958914
[TBL] [Abstract][Full Text] [Related]
18. TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain.
Prasad DD; Ouchida M; Lee L; Rao VN; Reddy ES
Oncogene; 1994 Dec; 9(12):3717-29. PubMed ID: 7970732
[TBL] [Abstract][Full Text] [Related]
19. Additional evidence of a variant translocation t(12;22) with EWS/CHOP fusion in myxoid liposarcoma: clinicopathological features.
Dal Cin P; Sciot R; Panagopoulos I; Aman P; Samson I; Mandahl N; Mitelman F; Van den Berghe H; Fletcher CD
J Pathol; 1997 Aug; 182(4):437-41. PubMed ID: 9306965
[TBL] [Abstract][Full Text] [Related]
20. Detection of TLS/FUS-CHOP fusion transcripts in a case of oral liposarcoma.
Rivero ER; Mesquita RA; de Sousa SC; Nunes FD
Ann Diagn Pathol; 2006 Feb; 10(1):36-8. PubMed ID: 16414544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
